Top Suppliers:I want be here

1425945-60-3

1425945-60-3 structure
1425945-60-3 structure
  • Name: EHT 5372
  • Chemical Name: EHT 5372
  • CAS Number: 1425945-60-3
  • Molecular Formula: C18H14FN5O2S
  • Molecular Weight: 383.40
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage CDK
  • Create Date: 2019-02-12 15:41:49
  • Modify Date: 2025-08-20 07:58:11
  • EHT 5372 is a strong inhibitor of DYRK’s family kinases, with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively.

Name EHT 5372
Description EHT 5372 is a strong inhibitor of DYRK’s family kinases, with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively.
Related Catalog
Target

CLK1:22.8 nM (IC50)

Clk2:88.8 nM (IC50)

Clk4:59 nM (IC50)

GSK3α:7.44 nM (IC50)

GSK3β:221 nM (IC50)

DYRK1A:0.22 nM (IC50)

DYRK1B:0.28 nM (IC50)

DYRK2:10.8 nM (IC50)

DYRK3:93.2 nM (IC50)

In Vitro EHT 5372 is a strong inhibitor of DYRK’s family kinases, with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively[1][2]. IC50 for DYRK2 and DYRK3 were higher (10.8 and 93.2 nM, respectively) and there was no inhibition on DYRK4. EHT 5372 displayed minimal impact on the CDC2-like kinase (CLK) family, with more than 100x selectivity over CLK1 (CLK1: IC50=22.8 nM; CLK2: IC50=88.8 nM; CLK3: IC50>10 lM; CLK4: no inhibition) and on the glycogen synthase kinase 3 (GSK3) family (GSK3α: IC50=7.44 nM; GSK3β: IC50=221 nM). EHT 5372 inhibits the direct phosphorylation of Tau by DYRK1A. EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ production[2].
Cell Assay HEK293 cells are changed with new culture medium and treated with 0.1-10 μM DYRK1A inhibitor EHT 5372 or 0.1% DMSO as vehicle for 24 h. The kinase inhibitor is tested in at least three independent experiments performed in duplicate. Cell viability is determined using a standard assay[2].
References

[1]. Chaikuad A, et al. An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases. J Med Chem. 2016 Nov 23;59(22):10315-10321.

[2]. Coutadeur S, et al. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. J Neurochem. 2015 May;133(3):440-51.

Molecular Formula C18H14FN5O2S
Molecular Weight 383.40
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.